Andriy Trailin

Laboratory of Translational Cancer Genomics,
Biomedical Center,
Faculty of Medicine in Pilsen,
Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen

Charles University

BIOGRAPHY

Andriy Trailin has not added Biography.

If you are Andriy Trailin and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Chronic Active Antibody-Mediated Rejection Is Associated With the Upregulation of Interstitial But Not Glomerular Transcripts.

Frontiers in immunology , 2021 | Pubmed ID: 34616398

Using virtual microscopy for the development of sampling strategies in quantitative histology and design-based stereology.

Anatomia, histologia, embryologia Jan, 2022 | Pubmed ID: 34806204

T- and B-Cells in the Inner Invasive Margin of Hepatocellular Carcinoma after Resection Associate with Favorable Prognosis.

Cancers Jan, 2022 | Pubmed ID: 35158872

CTNNB1 mutations, TERT polymorphism and CD8+ cell densities in resected hepatocellular carcinoma are associated with longer time to recurrence.

BMC cancer Aug, 2022 | Pubmed ID: 35962322

Long Non-Coding RNA and microRNA Interplay in Colorectal Cancer and Their Effect on the Tumor Microenvironment.

Cancers Nov, 2022 | Pubmed ID: 36358867

Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies.

International journal of molecular sciences Dec, 2022 | Pubmed ID: 36499616

Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances.

International journal of molecular sciences Apr, 2023 | Pubmed ID: 37175627

Morphological Changes of the Ovarian Vein in Pelvic Venous Disorders.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery Mar, 2024 | Pubmed ID: 37952635

miRNA and lncRNA as potential tissue biomarkers in hepatocellular carcinoma.

Non-coding RNA research Mar, 2024 | Pubmed ID: 38075204

Prognostic role of macrophages and mast cells in the microenvironment of hepatocellular carcinoma after resection.

BMC cancer Jan, 2024 | Pubmed ID: 38287290

INSTITUTIONS

Charles University

JOVE ARTICLES

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software

Esraa Ali¹,

Lenka Červenková^2,3,

Richard Pálek^2,4,

Filip Ambrozkiewicz¹,

Sergii Pavlov¹,

Wenjing Ye¹,

Petr Hošek²,

Ondrej Daum^5,6,

Václav Liška^2,4,

Kari Hemminki^1,7,

Andriy Trailin¹

¹Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University,

²Laboratory of Cancer Treatment and Tissue Regeneration, Biomedical Center, Faculty of Medicine in Pilsen, Charles University,

³Department of Pathology, Third Faculty of Medicine, Charles University,

⁴Department of Surgery and Biomedical Center, Faculty of Medicine in Pilsen, Charles University,

⁵Sikl's Institute of Pathology, Faculty of Medicine and Teaching Hospital in Pilsen, Charles University,

⁶, Bioptická Laboratoř s.r.o.,

⁷Department of Cancer Epidemiology, German Cancer Research Center

Cancer Research

政策

使用条款

隐私

联系我们

向图书馆推荐

JoVE 新闻简报

科研

JoVE Journal
技术专题合集
JoVE Encyclopedia of Experiments
档案

教育

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教师资源中心
Faculty Site

发表

概述
发表流程
编辑部
范围和政策
同行评审
常见问题
提交稿件

图书馆员

概述
客户评价
订阅
访问权限
资源
图书馆咨询委员会
常见问题

关于 JoVE

概述
管理层
博客
JoVE Help Center

Andriy Trailin

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Laboratory of Translational Cancer Genomics,Biomedical Center,Faculty of Medicine in Pilsen,Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen

Charles University

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software

Laboratory of Translational Cancer Genomics,
Biomedical Center,
Faculty of Medicine in Pilsen,
Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen